David P. Schenkein, Director at Denali Therapeutics Inc. (DNLI), sold 30,000 shares at $70.05 ($2.1M) on 2020-11-12, disclosed to the SEC on 2020-11-13.
Open-market sale of $2.1M DNLI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2024-02-27 | $4.5M | — | Filing → |
| AGIO | SELL | 2023-04-05 | $748K | — | Filing → |
| AGIO | SELL | 2023-03-29 | $443K | — | Filing → |